Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 5116 [2015-01817]
Download as PDF
5116
Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices
health equity issues and provide guidance on
opportunities for CDC.
Matters for Discussion: The Health
Disparities Subcommittee members will
discuss progress toward implementation of
the Health Disparities Subcommittee
recommendations and discussion of the
Healthy People 2020 progress review on
social determinants of health and LGBT
health.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K–77, Atlanta, Georgia 30333
Telephone (770) 488–8343, Email: LEL1@
cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2015–01766 Filed 1–29–15; 8:45 am]
BILLING CODE 4163–18–P
The meeting announced below
concerns Occupational Safety and
Health Education and Research Centers
(ERC) PAR 10–217, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Times and Dates:
6:00 p.m.–8:00 p.m., February 23, 2015
(Closed).
8:00 a.m.–6:00 p.m., February 24, 2015
(Closed).
8:00 a.m.–6:00 p.m., February 25, 2015
(Closed).
8:00 a.m.–6:00 p.m., February 26, 2015
(Closed).
Place: Renaissance Atlanta Midtown Hotel,
866 West Peachtree Street NW., Atlanta,
Georgia 30308, Telephone: (678) 412–2400.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Jkt 235001
George Bockosh, M.S., Scientific Review
Officer, National Institute for
Occupational Safety and Health
(NIOSH), CDC, 2400 Century Center
Parkway NE., 4th Floor, Mailstop E–74,
Atlanta, Georgia 30345, Telephone:
(412) 386–6465, GGB0@CDC.GOV and
Donald Blackman, Ph.D., Scientific
Review Officer, NIOSH, CDC, 2400
Century Center Parkway NE., 4th Floor,
Room 4204, Mailstop E–74, Atlanta,
Georgia 30345, Telephone: (404) 498–
6185, DYB7@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
18:50 Jan 29, 2015
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2015–01817 Filed 1–29–15; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Occupational Safety and Health
Education and Research Centers (ERC) PAR
10–217.’’
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns ‘‘Comprehensive High-Impact
HIV Prevention Projects for CommunityBased Organizations’’, Funding
Opportunity Announcement (FOA)
PS15–1502, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 9:00 a.m.–4:00 p.m. EST,
Panels 1–7; February 24, 2015 (Closed), 9:00
a.m.–4:00 p.m. EST, Panels 8–14; February
25, 2015 (Closed), 9:00 a.m.–4:00 p.m. EST,
Panels 15–19; February 26, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Comprehensive High-Impact
HIV Prevention Projects for CommunityBased Organizations’’ FOA PS15–1502.
Contact Person for More Information: Lisa
R. Williams, Public Health Analyst, CDC,
1600 Clifton Road NE., Mailstop E07,
Atlanta, Georgia 30333, Telephone: (404)
639–1877.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–01769 Filed 1–29–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
Times and Dates:
8:00 a.m.–5:45 p.m., February 25, 2015.
8:00 a.m.–1:00 p.m., February 26, 2015.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate use of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at
section 2713 of the Public Health Service
Act, immunization recommendations of the
ACIP that have been adopted by the Director
of the Centers for Disease Control and
Prevention must be covered by applicable
health plans.
Matters for discussion: The agenda will
include discussions on: General
recommendations; meningococcal vaccines;
human papillomavirus vaccines; influenza;
E:\FR\FM\30JAN1.SGM
30JAN1
Agencies
[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5116]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01817]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Occupational Safety and Health
Education and Research Centers (ERC) PAR 10-217, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Times and Dates:
6:00 p.m.-8:00 p.m., February 23, 2015 (Closed).
8:00 a.m.-6:00 p.m., February 24, 2015 (Closed).
8:00 a.m.-6:00 p.m., February 25, 2015 (Closed).
8:00 a.m.-6:00 p.m., February 26, 2015 (Closed).
Place: Renaissance Atlanta Midtown Hotel, 866 West Peachtree
Street NW., Atlanta, Georgia 30308, Telephone: (678) 412-2400.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Occupational Safety and Health Education and Research
Centers (ERC) PAR 10-217.''
FOR FURTHER INFORMATION CONTACT: George Bockosh, M.S., Scientific
Review Officer, National Institute for Occupational Safety and Health
(NIOSH), CDC, 2400 Century Center Parkway NE., 4th Floor, Mailstop E-
74, Atlanta, Georgia 30345, Telephone: (412) 386-6465, GGB0@CDC.GOV and
Donald Blackman, Ph.D., Scientific Review Officer, NIOSH, CDC, 2400
Century Center Parkway NE., 4th Floor, Room 4204, Mailstop E-74,
Atlanta, Georgia 30345, Telephone: (404) 498-6185, DYB7@CDC.GOV.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-01817 Filed 1-29-15; 8:45 am]
BILLING CODE 4163-18-P